Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mifepristone

EU orphan designation number: EU/3/09/614   
Active ingredient: Mifepristone
Indication: Treatment of hypercortisolism (Cushing´s syndrome) of endogenous origin
Sponsor: EXELGYN
216 boulevard Saint-Germain, F-75007 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Centralised Orphan - Designation EMEA/OD/086/08 (2009)1527 of 27/02/2009